Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

RAI Strategic Holdings Inc. Files Patent Infringement Case

Business by 2FIRSTS.ai
Jun.13.2024
RAI Strategic Holdings Inc. Files Patent Infringement Case
RAI Strategic Holdings, Inc. files patent infringement complaint with USITC against 42 companies for certain e-cigarette products.

On June 11, 2024, RAI Strategic Holdings, Inc., R.J. Reynolds Tobacco Company, RAI Services Company, and R.J. Reynolds Vapor Company filed a complaint with the United States International Trade Commission under Section 337 of the Tariff Act of 1930, alleging patent infringement of certain e-cigarette products exported from the US, imported into the US, or sold in the US. They requested the initiation of a Section 337 investigation and the issuance of a general exclusion order, limited exclusion order, and cease and desist orders. A total of 42 companies from the US, China, the UK, and other countries are involved in the case.

 

According to documents from the U.S. International Trade Commission, the following companies have been listed as proposed defendants by Reynolds Tobacco because they are suspected of importing, selling, or distributing disposable electronic vaporization devices and their components that allegedly infringe U.S. Patent No. 11,925,202 ("the '202 patent").

 

The proposed respondents include the following companies:

 

1. Breeze Smoke, LLC 2. Capital Sales Company 3. KMT Services, LLC doing business as KMT Distribution and Dank Shop 4. Dongguan (Shenzhen) Shikai Technology Co., Ltd. 5. Vapeonly Technology Co. Ltd. 6. iMiracle (Shenzhen) Technology Co., Ltd. 7. Guangdong Qisitech Co., Ltd. 8. Fewo Intelligent Manufacturing, Ltd. 9. Nevera (HK) Ltd. 10. Guangdong Cellular Workshop Electronics Technology Co., Ltd. 11. Wonder Ladies Ltd. 12. Sailing South Ltd. 13. Marea Morada Ltd. 14. Social Brands, LLC 15. Zhuhai Qisitech Co., Ltd. 16. Shenzhen Han Technology Co., Ltd. 17. Palma Terra Ltd. 18. Shenzhen IVPS Technology Co., Ltd. 19. Heaven Gifts International Ltd. 20. Maduro Distributors Inc. doing business as The Loon 21. Bidi Vapor, LLC 22. Kaival Brands Innovations Group Inc. 23. Kimsun Technology (HuiZhou) Co., Ltd. 24. Shenzhen Yanyang Technology Co., Ltd. 25. Pastel Cartel, LLC 26. American Vape Company, LLC 27. Affiliated Imports, LLC 28. Shenzhen Innokin Technology Co., Ltd. 29. Shenzhen Funyin Electronic Technology Co., Ltd. 30. Shenzhen LC Technology Co., Ltd. 31. LCF Labs, Inc. 32. Shenzhen Kangvape Technology Co., Ltd. 33. Flumgio Technology Ltd. 34. Shenzhen Pingray Technology 35. SV3 LLC doing business as Mi-One Brands 36. Price Point Distributors Inc. doing business as Price Point NY 37. Flawless Vape Shop Inc. 38. Flawless Vape Wholesale & Distribution Inc. 39. Thesy, LLC doing business as Element Vape 40. VICA Trading Inc. doing business as Vapesourcing 41. Ecto World, LLC doing business as Demand Vape 42. Midwest Goods Inc. doing business as Midwest Distribution

 

References:
[1] 美国企业对特定电子烟产品提起337调查申请
Also Read:
[1] US ITC Issues Final Rulings on Disposable E-cigarette 337 Investigation
[2] Reynolds 337 Case: ITC may Initiate Investigation after November 13
[3] Expert Insights on Reynolds 337 Investigation: Hard to Get ITC Abandon Jurisdiction
[4] Counsellor's Insights on Chinese E-Cig Enterprises Against Reynolds Tobacco 337 Investigation
#North America#United States#Disposable e-cigarettes#Regulation

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Regulation Shift：Policy Updates and Market Impact
China Tobacco Regulation Shift：Policy Updates and Market Impact
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
According to WNCY on August 24, 2026, some independent vape retailers in Wisconsin say they have faced significant business pressure one year after new vape regulations took effect. Johnny Vapes, a retailer operating in northeast Wisconsin, said its store count fell from seven locations to four, sales declined by about 80%, and roughly 90% of its inventory was affected. Retailers said some consumers have shifted to online purchases or traveled to neighboring Michigan to buy vape products. The case highlights how local regulations can reshape retail operations, inventory management and consumer purchasing patterns.
Aug.28
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Related Topics
News Regulation
Related Read
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2026 2FIRSTS. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland.
English
English
中文